"10.1371_journal.pone.0002675","plos one","2008-07-16T00:00:00Z","Esther J Kuiper; Frans A Van Nieuwenhoven; Marc D de Smet; Jan C van Meurs; Michael W Tanck; Noelynn Oliver; Ingeborg Klaassen; Cornelis J F Van Noorden; Roel Goldschmeding; Reinier O Schlingemann","Ocular Angiogenesis Group, Departments of Ophthalmology and Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Department of Pathology, Academic Medical Centre of Utrecht, Utrecht, The Netherlands; Department of Ophthalmology, Rotterdam Eye Hospital, Rotterdam, The Netherlands; Department of Clinical Epidemiological Statistics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; FibroGen Inc, San Francisco, California, United States of America","Conceived and designed the experiments: EJK RG ROS. Performed the experiments: EJK. Analyzed the data: MWT. Contributed reagents/materials/analysis tools: MDD JCV. Wrote the paper: EJK ROS. Overall responsibility for the coordination of the study: EJK. Collection of vitreous samples: EJK MDD JCV. Performed laboratory experiments: EJK. Interpretation of results: EJK FAV MDD JCV NO IK CJV RG. Preparation of the first drafts of the manuscript: EJK. Optimization of CTGF-ELISA and measurement of CTGF in vitreous samples: FAV. Supervision of all statistics: MWT. Supply of reagents: NO. Supervision of the laboratory experiments: IK. Preparation of the last version of the manuscript and supervision of the preparation of the manuscript: CJV. Supervision of part of the laboratory experiments: RG. Design of the study: ROS RG. Overall supervision of data collection: ROS.","Noelynn Oliver is an employee of Fibrogen Inc, Roel Goldschmeding has received research support grants from Fibrogen Inc.","2008","07","Esther J Kuiper","EJK",10,TRUE,3,1,1,2,TRUE,FALSE,FALSE,0,NA,FALSE
